ID: ALA4163382

Max Phase: Preclinical

Molecular Formula: C14H5NO3S2

Molecular Weight: 299.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1c2ccccc2C(=O)c2sc3nc(=O)sc-3cc21

Standard InChI:  InChI=1S/C14H5NO3S2/c16-10-6-3-1-2-4-7(6)11(17)12-8(10)5-9-13(20-12)15-14(18)19-9/h1-5H

Standard InChI Key:  GXCHGNRASGQSTG-UHFFFAOYSA-N

Associated Targets(Human)

SCC-15 194 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.33Molecular Weight (Monoisotopic): 298.9711AlogP: 2.45#Rotatable Bonds: 0
Polar Surface Area: 64.10Molecular Species: HBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.14CX LogD: 2.14
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.50Np Likeness Score: -0.19

References

1. Szychowski KA, Leja ML, Kaminskyy DV, Kryshchyshyn AP, Binduga UE, Pinyazhko OR, Lesyk RB, Tobiasz J, Gmiński J..  (2017)  Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).,  141  [PMID:29031063] [10.1016/j.ejmech.2017.09.071]

Source